search
Back to results

Monitoring Pupillary Reflex Dilatation for Optimized Postoperative Opioid Delivery Before Extubation.

Primary Purpose

Postoperative Pain

Status
Completed
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
Pupillometry-Opioid treatment
Pupillometry -standardized opioid treatment
Sponsored by
Medical University of Vienna
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Postoperative Pain focused on measuring Postoperative Pain, Infrared Pupillometry, Postoperative Opioid Consumption

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • American Society of Anesthesiology (ASA) physical status I-II
  • able to read and understand the information sheet and to sign the consent form
  • being scheduled for elective ENT surgery under general anesthesia
  • age≥18 years

Exclusion Criteria:

  • ASA physical status of III and above
  • previous history of either drug or alcohol abuse
  • difficulty to understand pain scoring system
  • chronic users of analgesics or had used opioids within 12 h before surgery
  • drug or alcohol abuse
  • contraindications for metamizole
  • preoperative topical eye medication (atropine, phenylephrine), preoperative pupil abnormality
  • concomitant treatment with beta-antagonists, metoclopramide or droperidol
  • implanted electronic medical devices
  • dysfunction of the autonomic nervous system in relation to advanced diabetes mellitus
  • ophthalmologic diseases, known pupil reflex disorders, cranial nerve lesions
  • rapid sequence induction (RSI)
  • neurological, psychiatric or mental disorders
  • surgical procedure warranting elective postoperative ventilation

Sites / Locations

  • Medical University Vienna

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

No Intervention

Arm Label

T30/60

Non-T30/60

Standard Care group

Arm Description

Before extubation, opioid administration will be given by a single dose of opioids in case of measured PDR values of ≥12.

A standardized single dose of opioid will be given intravenously before extubation, regardless of the measured pupillometry PDR values.

The amount of administered piritramid in the OR will be left to the discretion of the anesthesiologist attending the participant.

Outcomes

Primary Outcome Measures

Opioid consumption
cumulative opioid consumption within first 2 postoperative hours

Secondary Outcome Measures

postoperative pain intensity
Pain on an 11-point verbal Likert response score (VAS score) recorded by a blinded investigator at 30-minute intervals for the initial 2 postoperative hours. The 11-point numeric scale ranges between 0, meaning no pain, and 10, meaning worst pain.

Full Information

First Posted
October 13, 2020
Last Updated
August 29, 2023
Sponsor
Medical University of Vienna
search

1. Study Identification

Unique Protocol Identification Number
NCT04594382
Brief Title
Monitoring Pupillary Reflex Dilatation for Optimized Postoperative Opioid Delivery Before Extubation.
Official Title
Monitoring Pupillary Reflex Dilatation for Optimized Postoperative Opioid Delivery Before Extubation: A Randomized Pupillometry Study
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
October 21, 2020 (Actual)
Primary Completion Date
July 31, 2023 (Actual)
Study Completion Date
July 31, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Vienna

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The study will be designed to investigate the effect of pupillometry guided compared to non-PPI-guided postoperative pain therapy, conducted immediately at the end of surgery before extubation, on total postoperative opioid consumption during the first 2 postoperative hours after elective ear nose throat (ENT) surgery.
Detailed Description
Pupillometric pain measurements helps clinicians determine and administer the optimized amount of opioids and so avoids opioid-induced side effects.The study will be designed to investigate the effect of pupillometry guided compared to non-PPI-guided postoperative pain therapy, conducted before extubation, on total postoperative opioid consumption during the first 2 postoperative hours after elective ENT surgery. Background The evaluation of pain intensity during the immediate postoperative period in the operating room (OR) is a key factor for post interventional pain treatment. However, this evaluation may be difficult when patients are still intubated, restricted in consciousness or are showing verbal impairment due to ENT surgery. Verbally impaired patients are at increased risk of under treatment for pain. With rising opioid consumption, the risk of postoperative side effects like nausea and vomiting, sedation with a longer recovery time or respiratory depression increases. Especially in the cohort of ENT surgery patients, where a difficult airway is regularly presented, such side effects should be avoided. A means of predicting immediate postoperative pain after surgery and the response to opiate analgesics would therefore be highly desirable. The pupillary dilatation reflex (PDR), measured by pupillometry, has been successfully used to assess intraoperative analgesic component of anesthetic regimes and correlates with pain intensity measured on a numeric rating scale (NRS). Aims Primary aim of this study is to investigate if a pupillometry-guided opioid administration immediately postoperative in the OR leads to less opioid requirement during the first 2 postoperative hours compared to a non-pupillometry-guided treatment. Secondary aim is to evaluate postoperative pain intensity during the first 2 postoperative hours in patients after pupillometry-guided versus non-pupillometry -guided opioid therapy in the OR. Hypotheses The investigators hypothesis that through a targeted pain therapy based on the measurement of immediate postoperative pupillometry scores, opioid consumption and pain intensity can be reduced during the first 2 postoperative hours. Methods The study will be done by observing postoperative pain intensity using pupillometry in patients scheduled for elective ENT surgery, carrying out pain intervention (opioid therapy) and re-observing to verify the effectiveness of the targeted postoperative opioid administration in the OR. Pain on an 11-point verbal Likert response score and total opioid consumption will be recorded by a blinded investigator at 30-minute intervals for the initial 2 postoperative hours.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain
Keywords
Postoperative Pain, Infrared Pupillometry, Postoperative Opioid Consumption

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
140 (Actual)

8. Arms, Groups, and Interventions

Arm Title
T30/60
Arm Type
Active Comparator
Arm Description
Before extubation, opioid administration will be given by a single dose of opioids in case of measured PDR values of ≥12.
Arm Title
Non-T30/60
Arm Type
Active Comparator
Arm Description
A standardized single dose of opioid will be given intravenously before extubation, regardless of the measured pupillometry PDR values.
Arm Title
Standard Care group
Arm Type
No Intervention
Arm Description
The amount of administered piritramid in the OR will be left to the discretion of the anesthesiologist attending the participant.
Intervention Type
Diagnostic Test
Intervention Name(s)
Pupillometry-Opioid treatment
Intervention Description
At the end of anesthesia, before extubation, pupillometry measurements will be performed on both eyes, using the tetanus mode T30 (30mA tetanic stimulation) and T60 (60mA tetanic stimulation) and the standardized pupillary pain index (PPI) mode at the pupillometer. Opioid administration will be given by a single dose of piritramid (0.1 mg kg -1) in case of measured PDR values of ≥12 (high analgesic sensitivity as specified by the producer) after T30 and T60 stimulation. The pupillometry measurement will be repeated once on both eyes.
Intervention Type
Diagnostic Test
Intervention Name(s)
Pupillometry -standardized opioid treatment
Intervention Description
At the end of anesthesia, before extubation, pupillometry measurements will be performed on both eyes, using the tetanus mode T30 (30mA tetanic stimulation) and T60 (60mA tetanic stimulation) and the standardized pupillary pain index (PPI) mode at the pupillometer. A standardized single dose of piritramid (0,1 mg kg -1) will be given intravenously, regardless of the measured values. The pupillometry measurement will be repeated once on both eyes.
Primary Outcome Measure Information:
Title
Opioid consumption
Description
cumulative opioid consumption within first 2 postoperative hours
Time Frame
first 2 postoperative hours
Secondary Outcome Measure Information:
Title
postoperative pain intensity
Description
Pain on an 11-point verbal Likert response score (VAS score) recorded by a blinded investigator at 30-minute intervals for the initial 2 postoperative hours. The 11-point numeric scale ranges between 0, meaning no pain, and 10, meaning worst pain.
Time Frame
first 2 postoperative hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: American Society of Anesthesiology (ASA) physical status I-II able to read and understand the information sheet and to sign the consent form being scheduled for elective ENT surgery under general anesthesia age≥18 years Exclusion Criteria: ASA physical status of III and above previous history of either drug or alcohol abuse difficulty to understand pain scoring system chronic users of analgesics or had used opioids within 12 h before surgery drug or alcohol abuse contraindications for metamizole preoperative topical eye medication (atropine, phenylephrine), preoperative pupil abnormality concomitant treatment with beta-antagonists, metoclopramide or droperidol implanted electronic medical devices dysfunction of the autonomic nervous system in relation to advanced diabetes mellitus ophthalmologic diseases, known pupil reflex disorders, cranial nerve lesions rapid sequence induction (RSI) neurological, psychiatric or mental disorders surgical procedure warranting elective postoperative ventilation
Facility Information:
Facility Name
Medical University Vienna
City
Vienna
ZIP/Postal Code
1090
Country
Austria

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Monitoring Pupillary Reflex Dilatation for Optimized Postoperative Opioid Delivery Before Extubation.

We'll reach out to this number within 24 hrs